 Julie Dunn
Concepts (233)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cognition Disorders | 3 | 2011 | 496 | 0.530 |
Why?
| | Wounds, Nonpenetrating | 4 | 2022 | 278 | 0.490 |
Why?
| | Population Surveillance | 4 | 2020 | 482 | 0.470 |
Why?
| | Trauma Centers | 7 | 2022 | 421 | 0.420 |
Why?
| | Wounds and Injuries | 4 | 2022 | 758 | 0.400 |
Why?
| | Heart Defects, Congenital | 4 | 2020 | 842 | 0.370 |
Why?
| | Trans Fatty Acids | 1 | 2011 | 6 | 0.360 |
Why?
| | Fatty Acids, Monounsaturated | 1 | 2011 | 54 | 0.350 |
Why?
| | Carotid Artery Injuries | 2 | 2022 | 41 | 0.330 |
Why?
| | Thoracic Injuries | 2 | 2020 | 55 | 0.300 |
Why?
| | Dental Amalgam | 1 | 2007 | 3 | 0.280 |
Why?
| | Fatty Acids | 1 | 2011 | 443 | 0.280 |
Why?
| | Mercury | 1 | 2007 | 41 | 0.270 |
Why?
| | Hair | 1 | 2007 | 84 | 0.270 |
Why?
| | alpha-Tocopherol | 1 | 2007 | 33 | 0.270 |
Why?
| | Vascular System Injuries | 2 | 2017 | 71 | 0.260 |
Why?
| | Vitamin E | 1 | 2007 | 124 | 0.260 |
Why?
| | Dietary Supplements | 2 | 2022 | 561 | 0.230 |
Why?
| | Cerebrovascular Trauma | 2 | 2022 | 17 | 0.220 |
Why?
| | Stroke | 3 | 2022 | 1120 | 0.200 |
Why?
| | Telemetry | 1 | 2022 | 40 | 0.190 |
Why?
| | Syncope | 1 | 2022 | 52 | 0.190 |
Why?
| | Vertebral Artery | 1 | 2022 | 26 | 0.190 |
Why?
| | Health Services Needs and Demand | 2 | 2020 | 273 | 0.180 |
Why?
| | Survivors | 2 | 2024 | 493 | 0.180 |
Why?
| | Middle Aged | 19 | 2022 | 33479 | 0.180 |
Why?
| | Advance Directives | 1 | 2022 | 72 | 0.180 |
Why?
| | Hemothorax | 1 | 2020 | 11 | 0.170 |
Why?
| | Accidental Falls | 2 | 2020 | 196 | 0.170 |
Why?
| | Thoracostomy | 1 | 2020 | 17 | 0.170 |
Why?
| | Wilderness | 1 | 2020 | 16 | 0.170 |
Why?
| | Vitamin D Deficiency | 1 | 2022 | 186 | 0.170 |
Why?
| | Biological Specimen Banks | 1 | 2021 | 102 | 0.170 |
Why?
| | Chest Tubes | 1 | 2020 | 29 | 0.170 |
Why?
| | Mountaineering | 1 | 2020 | 40 | 0.170 |
Why?
| | Adult | 20 | 2024 | 37929 | 0.170 |
Why?
| | Hypoventilation | 1 | 2019 | 11 | 0.160 |
Why?
| | Congenital Abnormalities | 2 | 2018 | 92 | 0.160 |
Why?
| | Head Injuries, Penetrating | 1 | 2019 | 5 | 0.160 |
Why?
| | Pregnancy Rate | 1 | 2019 | 65 | 0.160 |
Why?
| | Geographic Information Systems | 1 | 2019 | 45 | 0.160 |
Why?
| | Musculoskeletal Diseases | 2 | 2014 | 78 | 0.160 |
Why?
| | Pregnancy Complications, Cardiovascular | 1 | 2019 | 77 | 0.160 |
Why?
| | Aged | 14 | 2022 | 23961 | 0.150 |
Why?
| | Anticoagulants | 2 | 2022 | 664 | 0.150 |
Why?
| | Wound Infection | 1 | 2019 | 32 | 0.150 |
Why?
| | Monocytes | 1 | 2022 | 563 | 0.150 |
Why?
| | Brain Injuries, Traumatic | 2 | 2020 | 360 | 0.140 |
Why?
| | Splenic Artery | 1 | 2017 | 14 | 0.140 |
Why?
| | Female | 22 | 2022 | 73304 | 0.140 |
Why?
| | Shock, Hemorrhagic | 1 | 2019 | 167 | 0.140 |
Why?
| | Splenectomy | 1 | 2017 | 62 | 0.140 |
Why?
| | Carbon Dioxide | 1 | 2019 | 267 | 0.140 |
Why?
| | Aneurysm, False | 1 | 2017 | 48 | 0.140 |
Why?
| | Massachusetts | 5 | 2019 | 172 | 0.140 |
Why?
| | Resuscitation | 1 | 2019 | 251 | 0.140 |
Why?
| | Injury Severity Score | 4 | 2020 | 522 | 0.130 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2020 | 463 | 0.130 |
Why?
| | Abdominal Injuries | 1 | 2017 | 123 | 0.130 |
Why?
| | Venous Thromboembolism | 1 | 2020 | 316 | 0.130 |
Why?
| | Endothelial Cells | 1 | 2022 | 785 | 0.130 |
Why?
| | Pain | 3 | 2014 | 756 | 0.120 |
Why?
| | Young Adult | 10 | 2022 | 13209 | 0.120 |
Why?
| | Humans | 29 | 2024 | 137585 | 0.120 |
Why?
| | Fibrinolytic Agents | 1 | 2018 | 270 | 0.120 |
Why?
| | Foot Diseases | 2 | 2005 | 15 | 0.120 |
Why?
| | Spleen | 1 | 2017 | 514 | 0.120 |
Why?
| | Aorta, Thoracic | 1 | 2017 | 267 | 0.120 |
Why?
| | Rural Population | 1 | 2019 | 563 | 0.120 |
Why?
| | Activities of Daily Living | 3 | 2014 | 413 | 0.110 |
Why?
| | Male | 18 | 2022 | 67762 | 0.110 |
Why?
| | Zika Virus Infection | 1 | 2017 | 165 | 0.110 |
Why?
| | Pregnancy Complications | 1 | 2019 | 527 | 0.110 |
Why?
| | Georgia | 3 | 2019 | 86 | 0.110 |
Why?
| | Acupuncture Therapy | 1 | 2014 | 21 | 0.110 |
Why?
| | Prevalence | 4 | 2019 | 2734 | 0.110 |
Why?
| | Athletic Injuries | 1 | 2020 | 529 | 0.110 |
Why?
| | Connective Tissue Diseases | 1 | 2014 | 84 | 0.100 |
Why?
| | Endovascular Procedures | 1 | 2017 | 312 | 0.100 |
Why?
| | Risk Factors | 5 | 2022 | 10388 | 0.100 |
Why?
| | Retrospective Studies | 9 | 2024 | 15657 | 0.100 |
Why?
| | Migraine Disorders | 1 | 2014 | 102 | 0.100 |
Why?
| | United States | 8 | 2022 | 14841 | 0.100 |
Why?
| | Aged, 80 and over | 5 | 2022 | 7635 | 0.090 |
Why?
| | Health Services Accessibility | 1 | 2019 | 986 | 0.090 |
Why?
| | Prospective Studies | 4 | 2022 | 7604 | 0.090 |
Why?
| | Illinois | 1 | 2011 | 43 | 0.090 |
Why?
| | Least-Squares Analysis | 1 | 2011 | 79 | 0.090 |
Why?
| | Diet Surveys | 1 | 2011 | 95 | 0.090 |
Why?
| | Pain Management | 1 | 2014 | 352 | 0.090 |
Why?
| | Colorado | 4 | 2022 | 4565 | 0.090 |
Why?
| | Logistic Models | 3 | 2020 | 2074 | 0.090 |
Why?
| | Comorbidity | 4 | 2022 | 1622 | 0.080 |
Why?
| | Patient Satisfaction | 1 | 2014 | 660 | 0.080 |
Why?
| | Adolescent | 8 | 2022 | 21513 | 0.080 |
Why?
| | New York | 2 | 2019 | 126 | 0.080 |
Why?
| | Linear Models | 1 | 2011 | 849 | 0.070 |
Why?
| | Child | 7 | 2022 | 21935 | 0.070 |
Why?
| | Time Factors | 4 | 2020 | 6828 | 0.070 |
Why?
| | Chewing Gum | 1 | 2007 | 9 | 0.070 |
Why?
| | Longitudinal Studies | 3 | 2022 | 2844 | 0.070 |
Why?
| | Fishes | 1 | 2007 | 105 | 0.070 |
Why?
| | Chicago | 1 | 2007 | 61 | 0.070 |
Why?
| | Self Report | 1 | 2011 | 827 | 0.070 |
Why?
| | Neuropsychological Tests | 1 | 2011 | 1023 | 0.070 |
Why?
| | Multivariate Analysis | 2 | 2020 | 1509 | 0.060 |
Why?
| | Hospitalization | 3 | 2022 | 2199 | 0.060 |
Why?
| | Surveys and Questionnaires | 2 | 2011 | 5778 | 0.060 |
Why?
| | Statistics as Topic | 1 | 2007 | 307 | 0.060 |
Why?
| | Follow-Up Studies | 3 | 2021 | 5131 | 0.060 |
Why?
| | Length of Stay | 2 | 2022 | 1215 | 0.060 |
Why?
| | Hospital Mortality | 2 | 2022 | 911 | 0.060 |
Why?
| | Muscle Weakness | 1 | 2005 | 88 | 0.060 |
Why?
| | Disease Progression | 2 | 2024 | 2757 | 0.060 |
Why?
| | Risk Assessment | 2 | 2020 | 3457 | 0.060 |
Why?
| | Tomography, X-Ray Computed | 3 | 2020 | 2691 | 0.050 |
Why?
| | Women's Health | 1 | 2007 | 372 | 0.050 |
Why?
| | Convalescence | 1 | 2024 | 17 | 0.050 |
Why?
| | Pregnancy Complications, Infectious | 2 | 2019 | 394 | 0.050 |
Why?
| | Ki-67 Antigen | 1 | 2024 | 112 | 0.050 |
Why?
| | CD3 Complex | 1 | 2024 | 106 | 0.050 |
Why?
| | Cognition | 1 | 2011 | 1153 | 0.050 |
Why?
| | Incidence | 2 | 2020 | 2804 | 0.050 |
Why?
| | Chest Pain | 1 | 2024 | 91 | 0.050 |
Why?
| | Age Factors | 2 | 2022 | 3295 | 0.050 |
Why?
| | Calcifediol | 1 | 2022 | 33 | 0.050 |
Why?
| | Patient Acuity | 1 | 2022 | 47 | 0.050 |
Why?
| | Cholecalciferol | 1 | 2022 | 60 | 0.050 |
Why?
| | CD56 Antigen | 1 | 2022 | 35 | 0.050 |
Why?
| | Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2022 | 52 | 0.050 |
Why?
| | Dyspnea | 1 | 2024 | 254 | 0.050 |
Why?
| | Lymphopenia | 1 | 2022 | 62 | 0.050 |
Why?
| | Lymphocyte Subsets | 1 | 2022 | 87 | 0.050 |
Why?
| | Diagnostic Tests, Routine | 1 | 2022 | 110 | 0.040 |
Why?
| | Leukocytes, Mononuclear | 1 | 2024 | 558 | 0.040 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2022 | 109 | 0.040 |
Why?
| | Chromatography, Liquid | 1 | 2022 | 433 | 0.040 |
Why?
| | Immunophenotyping | 1 | 2022 | 318 | 0.040 |
Why?
| | Chemoprevention | 1 | 2020 | 92 | 0.040 |
Why?
| | Essential Hypertension | 1 | 2019 | 5 | 0.040 |
Why?
| | Hyperemesis Gravidarum | 1 | 2019 | 5 | 0.040 |
Why?
| | Specimen Handling | 1 | 2021 | 183 | 0.040 |
Why?
| | Obstetric Labor, Premature | 1 | 2019 | 36 | 0.040 |
Why?
| | Pregnancy Complications, Hematologic | 1 | 2019 | 24 | 0.040 |
Why?
| | Drainage | 1 | 2020 | 173 | 0.040 |
Why?
| | Blood Gas Analysis | 1 | 2019 | 74 | 0.040 |
Why?
| | Tandem Mass Spectrometry | 1 | 2022 | 532 | 0.040 |
Why?
| | Diet | 1 | 2007 | 1278 | 0.040 |
Why?
| | Tidal Volume | 1 | 2019 | 86 | 0.040 |
Why?
| | Exsanguination | 1 | 2019 | 19 | 0.040 |
Why?
| | Treatment Outcome | 3 | 2020 | 10811 | 0.040 |
Why?
| | Cardiac Imaging Techniques | 1 | 2019 | 21 | 0.040 |
Why?
| | Echocardiography | 1 | 2022 | 642 | 0.040 |
Why?
| | Morbidity | 1 | 2020 | 324 | 0.040 |
Why?
| | Vitamin D | 1 | 2022 | 397 | 0.040 |
Why?
| | Medically Uninsured | 1 | 2019 | 130 | 0.040 |
Why?
| | Hyperlipidemias | 1 | 2019 | 120 | 0.040 |
Why?
| | Hypertension, Pregnancy-Induced | 1 | 2019 | 69 | 0.040 |
Why?
| | International Classification of Diseases | 1 | 2019 | 135 | 0.040 |
Why?
| | Information Storage and Retrieval | 1 | 2019 | 118 | 0.040 |
Why?
| | Terminal Care | 1 | 2022 | 232 | 0.040 |
Why?
| | Epidemiological Monitoring | 1 | 2018 | 60 | 0.040 |
Why?
| | Cohort Studies | 2 | 2024 | 5742 | 0.040 |
Why?
| | Statistics, Nonparametric | 1 | 2019 | 431 | 0.040 |
Why?
| | Anemia | 1 | 2019 | 170 | 0.040 |
Why?
| | Antibiotic Prophylaxis | 1 | 2019 | 119 | 0.040 |
Why?
| | Emergency Service, Hospital | 2 | 2020 | 2069 | 0.040 |
Why?
| | Insurance Coverage | 1 | 2019 | 230 | 0.040 |
Why?
| | Reference Values | 1 | 2019 | 816 | 0.040 |
Why?
| | Plasma | 1 | 2019 | 212 | 0.040 |
Why?
| | Flow Cytometry | 1 | 2022 | 1178 | 0.040 |
Why?
| | Aortography | 1 | 2017 | 52 | 0.030 |
Why?
| | Lymphocyte Activation | 1 | 2022 | 1142 | 0.030 |
Why?
| | Antibodies, Viral | 1 | 2022 | 625 | 0.030 |
Why?
| | Monitoring, Physiologic | 1 | 2019 | 275 | 0.030 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2024 | 1091 | 0.030 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2024 | 900 | 0.030 |
Why?
| | Respiration, Artificial | 1 | 2022 | 645 | 0.030 |
Why?
| | Arrhythmias, Cardiac | 1 | 2019 | 333 | 0.030 |
Why?
| | Multiple Trauma | 1 | 2017 | 100 | 0.030 |
Why?
| | North Carolina | 1 | 2017 | 110 | 0.030 |
Why?
| | Cause of Death | 1 | 2019 | 434 | 0.030 |
Why?
| | Thoracic Surgical Procedures | 1 | 2017 | 73 | 0.030 |
Why?
| | Blood Vessel Prosthesis | 1 | 2017 | 127 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 1 | 2019 | 889 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2024 | 2475 | 0.030 |
Why?
| | Neutrophils | 1 | 2022 | 1238 | 0.030 |
Why?
| | Thrombosis | 1 | 2019 | 371 | 0.030 |
Why?
| | Wounds, Gunshot | 1 | 2019 | 228 | 0.030 |
Why?
| | Nervous System Diseases | 1 | 2018 | 266 | 0.030 |
Why?
| | Pregnancy | 2 | 2019 | 6763 | 0.030 |
Why?
| | Medicaid | 1 | 2019 | 435 | 0.030 |
Why?
| | Embolization, Therapeutic | 1 | 2017 | 229 | 0.030 |
Why?
| | Diabetes, Gestational | 1 | 2019 | 318 | 0.030 |
Why?
| | Pilot Projects | 1 | 2020 | 1710 | 0.030 |
Why?
| | Ambulatory Care | 1 | 2019 | 546 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2020 | 827 | 0.030 |
Why?
| | Medicine, East Asian Traditional | 1 | 2014 | 2 | 0.030 |
Why?
| | Decision Making | 1 | 2022 | 900 | 0.030 |
Why?
| | Pneumonia | 1 | 2020 | 639 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2019 | 2031 | 0.030 |
Why?
| | Medicare | 1 | 2019 | 773 | 0.030 |
Why?
| | Infant, Newborn | 2 | 2017 | 6079 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2022 | 2828 | 0.030 |
Why?
| | Hospitals | 1 | 2018 | 691 | 0.030 |
Why?
| | Stents | 1 | 2017 | 527 | 0.030 |
Why?
| | Public Health | 1 | 2018 | 588 | 0.030 |
Why?
| | Cardiac Surgical Procedures | 1 | 2019 | 530 | 0.030 |
Why?
| | Coronary Artery Disease | 1 | 2019 | 698 | 0.030 |
Why?
| | Sex Factors | 1 | 2019 | 2071 | 0.030 |
Why?
| | Survival Rate | 1 | 2017 | 1972 | 0.020 |
Why?
| | Databases, Factual | 1 | 2018 | 1357 | 0.020 |
Why?
| | Emergency Medical Services | 1 | 2019 | 552 | 0.020 |
Why?
| | Inflammation | 1 | 2024 | 2837 | 0.020 |
Why?
| | Hypertension | 1 | 2022 | 1295 | 0.020 |
Why?
| | Ambulatory Care Facilities | 1 | 2014 | 232 | 0.020 |
Why?
| | Quality of Life | 1 | 2024 | 2892 | 0.020 |
Why?
| | Child, Preschool | 2 | 2018 | 11074 | 0.020 |
Why?
| | Infant | 2 | 2017 | 9465 | 0.020 |
Why?
| | Registries | 1 | 2018 | 2035 | 0.020 |
Why?
| | Biomarkers | 1 | 2022 | 4149 | 0.020 |
Why?
| | Socioeconomic Factors | 1 | 2014 | 1289 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2019 | 1809 | 0.020 |
Why?
| | Obesity | 1 | 2022 | 2992 | 0.020 |
Why?
| | Cross-Sectional Studies | 2 | 2011 | 5472 | 0.020 |
Why?
| | Fasciitis, Plantar | 1 | 2005 | 4 | 0.020 |
Why?
| | Foot Deformities | 1 | 2005 | 10 | 0.010 |
Why?
| | Ankle | 1 | 2005 | 60 | 0.010 |
Why?
| | Animals | 1 | 2007 | 36940 | 0.010 |
Why?
| | Random Allocation | 1 | 2005 | 353 | 0.010 |
Why?
| | Models, Statistical | 1 | 2005 | 669 | 0.010 |
Why?
| | Health Status | 1 | 2005 | 792 | 0.010 |
Why?
| | Body Mass Index | 1 | 2005 | 2389 | 0.010 |
Why?
|
|
Dunn's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|